News from 2021
MVM invests in eXmoor Pharma
MVM led a financing of eXmoor Pharma, an expert cell and gene therapy services company.
Hologic announces acquisition of Biotheranostics
Hologic, Inc., a global leader in women's health, announced today that it has agreed to acquire Biotheranostics, Inc., a privately held, commercial-stage company that provides molecular diagnostic tests for breast and metastatic cancers.
MVM Winter 2020 Newsletter
Recent updates regarding MVM team, new investments, and portfolio.